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Abstract
Background: Obesity is related to multiple cardiovascular disease (CVD) risk factors as well as
CVD and has a strong familial component. We tested for association between SNPs on the
Affymetrix 100K SNP GeneChip and measures of adiposity in the Framingham Heart Study.
Methods: A total of 1341 Framingham Heart Study participants in 310 families genotyped with the
Affymetrix 100K SNP GeneChip had adiposity traits measured over 30 years of follow up. Body
mass index (BMI), waist circumference (WC), weight change, height, and radiographic measures of
adiposity (subcutaneous adipose tissue, visceral adipose tissue, waist circumference, sagittal height)
were measured at multiple examination cycles. Multivariable-adjusted residuals, adjusting for age,
age-squared, sex, smoking, and menopausal status, were evaluated in association with the genotype
data using additive Generalized Estimating Equations (GEE) and Family Based Association Test
(FBAT) models. We prioritized mean BMI over offspring examinations (1–7) and cohort
examinations (10, 16, 18, 20, 22, 24, 26) and mean WC over offspring examinations (4–7) for
presentation. We evaluated associations with 70,987 SNPs on autosomes with minor allele
frequencies of at least 0.10, Hardy-Weinberg equilibrium p ≥ 0.001, and call rates of at least 80%.
Results: The top SNPs to be associated with mean BMI and mean WC by GEE were rs110683 (p-
value 1.22*10-7) and rs4471028 (p-values 1.96*10-7). Please see http://www.ncbi.nlm.nih.gov/
projects/gap/cgi-bin/study.cgi?id=phs000007 for the complete set of results. We were able to
validate SNPs in known genes that have been related to BMI or other adiposity traits, including the
ESR1 Xba1 SNP, PPARG, and ADIPOQ.
Conclusion: Adiposity traits are associated with SNPs on the Affymetrix 100K SNP GeneChip.
Replication of these initial findings is necessary. These data will serve as a resource for replication
as more genes become identified with BMI and WC.
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Cardiovascular disease (CVD) is the leading cause of mor-
bidity and mortality in the United States, affecting
roughly twelve million people and accounting for nearly
one million deaths per year [1]. Although improvements
in cardiovascular risk factor profiles have contributed to
reductions in CVD mortality, an increasing prevalence of
obesity may have slowed this rate of decline [2]. Obesity
increases the risk of all-cause mortality [3], vascular dis-
ease [4], and non-vascular causes of death including cer-
tain cancers [5]. Genetic and environmental factors have
been linked to obesity [6]. We have previously reported
linkage to body mass index (BMI) on chromosomes 6q23
and 11q24 [7,8], waist circumference (WC) on chromo-
some 6q23 [9], and weight change on chromosome
20q13 [10] in the Framingham Heart Study. Additionally,
multiple quantitative trait loci and candidate genes have
been mapped to adiposity-related traits, as recently
reviewed [11].
As part of the Framingham Heart Study 100K Project, we
sought to test the relation of multiple adiposity-related
traits with the Affymetrix one hundred thousand single
nucleotide polymorphisms (SNP) chip. A broad range of
phenotypes were studied and include BMI, WC, height,
and radiographic quantification of subcutaneous (SAT)
and visceral (VAT) fat. In this manuscript we focus on
mean BMI and mean WC. We tested the relation of these
traits to 70,987 SNPs.
Methods
Participants from the Framingham Heart Study Original
Cohort and Offspring Cohort underwent genotyping with
the Affymetrix 100K GeneChip; details about the selection
process and genotyping are provided in the Overview
[12]. Participants (n = 1345) were genotyped for the
Affymetrix GeneChip Human Mapping 100K SNP set. For
the current analysis, phenotype data were available in
1341 participants for mean BMI and 1079 participants for
mean WC. For this manuscript, we focused on mean BMI
over offspring examinations (1–7) and cohort examina-
tions (10, 16, 18, 20, 22, 24, 26) and mean WC over off-
spring examinations (4–7). We evaluated associations
with 70,987 SNPs on autosomes with minor allele fre-
quencies ≥ 0.10, Hardy-Weinberg equilibrium (HWE) p-
value ≥ 0.001, and call rates ≥80%.
Phenotype assessment
Body weight and height were measured at all 7 Offspring
examination cycles, from 1971 to 2001 and chronologi-
cally corresponding to 7 Original cohort examinations
(10, 16, 18, 20, 22, 24, 26); WC was measured at the level
of the umbilicus at 4 Offspring examinations (4, 5, 6, and
7). BMI was calculated by taking the weight (in kilograms)
over the height (in meters-squared). Mean BMI across 7
offspring examinations (1–7) and 7 cohort examinations
(10, 16, 18, 20, 22, 24, 26) was obtained by taking the
average of all available measurements; mean WC across 4
examinations was obtained by taking the average of all
available offspring measurements. Covariates were also
averaged over the exams at which the adiposity measures
were available.
Subcutaneous and visceral fat volumes (SAT and VAT,
respectively) were measured on a subset of individuals
who took part in the Framingham Offspring Multi-Detec-
tor Computed Tomography Study between 2002 and
2005. Briefly, subjects underwent eight-slice multi-detec-
tor computed tomography imaging of the chest and abdo-
men in a supine position as previously described
(LightSpeed Ultra, General Electric, Milwaukee, WI) [13].
SAT and VAT volumes were assessed (Aquarius 3D Work-
station, TeraRecon Inc., San Mateo, CA) via manual trac-
ing of the abdominal muscular wall that separates the
visceral from the subcutaneous compartment, with excel-
lent inter-reader variability of 0.99 for VAT and SAT, as
previously reported [13].
Genotyping
Genotyping was performed using the 100K Affymetrix
GeneChip. Please see the Overview [12] for details.
Statistical methods
In total, a maximum of 1341 genotyped participants with
phenotype information were available for analysis. Resid-
uals were created from multiple linear regression models
to adjust traits for covariates; these residuals were created
separately in the Original Cohort and Offspring, and in
women and men separately. The standardized residuals
from these regression models were used to create ranked
normalized deviates, which were in turn used for genetic
analyses. Adiposity traits were age-adjusted (age and age-
squared) and then multivariable adjusted; details of mul-
tivariable adjustment for each trait are presented in Table
1. Only multivariable-adjusted results are presented in
this manuscript. All association analyses were performed
using generalized estimating equations (GEE) and family-
based association testing (FBAT); variance component
methods were used for linkage; details are provided in the
Overview [12]. To consider concordance of results among
correlated adiposity traits (see the third table in this arti-
cle), we selected SNPs with significant association (p <
0.01 in GEE or FBAT analyses) for at least 6 out of 8 fol-
lowing weight-related traits: BMI at Offspring exams 1–7
and chronologically corresponding Cohort exams 10, 16,
18, 20, 22, 24, 26 and mean BMI from these exams, and
computed a geometric mean GEE p-values across all 8
traits for FBAT and GEE separately. We evaluated associa-
tions with 70,987 SNPs on autosomes with minor allele
frequencies of at least 0.10, HWE p ≥ 0.001, and call ratesPage 2 of 7
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iance components methods on a subset of 100K markers
in linkage equilibrium and Marshfield short tandem
repeats; please see the Overview [12] for more details,
including power calculations.
Results
All traits (n = 157), including relevant examination cycles
and multivariable-adjustments, are presented in Table 1.
Table 2a presents the top 25 p-values obtained via GEE for
mean BMI and mean WC. The top SNPs to be associated
with mean BMI and mean WC by GEE were rs110683 (p-
value 1.22*10-7) and rs4471028 (p-values 1.9*10-7);
Table 2b presents the top SNPs for the FBAT procedure.
Additional results can be found on the following website:
http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/
study.cgi?id=phs000007. Table 2c presents all LOD scores
of at least 2.0. For mean BMI, we observed a peak LOD
score of 2.3 on chromosome 2p16, whereas for mean WC,
we observed a peak LOD score of 2.3 on chromosome
2q14.
Table 3 presents the top 25 SNPs for our multiple traits
analysis, summarizing concordance of results in related
BMI traits. The SNP with the lowest p-value was
rs1106683 (p-value 3.8*10-6). We also evaluated 4 well-
replicated genes in the obesity field (ADIPOQ [14], ESR1
[15], LEP [16], and PPARG [17]), as well as the recently
identified INSIG2 gene [18]; Table 4a displays the associ-
ated validated SNPs from the literature that are either
present in the Affymetrix 100K or that are in linkage dise-
quilibrium (LD) with these SNPs. We found significant
results for a SNP in LD with the ESR1 Xba1 SNP
(rs3853250; FBAT p-value for mean BMI = 0.047). We
also confirmed the association between a SNP in the
INSIG2 gene (rs7566605; GEE p-value 0.001 for mean
BMI) previously identified in this sample using a different
analytic method [18]. We further explored associations
with all SNPs in the Affymetrix 100K either within these
genes or within 200 kb of these genes (Table 4b); only
associations with p < 0.05 are presented. We identified 3
additional associated SNPs in the INSIG2 gene, 5 SNPs in
the PPARG gene, 1 SNP in the ADIPOQ gene, and 5 SNPs
in the ESR1 gene. Of the 4 SNPs present in the LEP gene,
there were no associations with a p-value < 0.05.
Additional Findings
We also identified several additional SNPs in genes in
relation to mean BMI or mean WC among our list of the
top 500 SNPs http://www.ncbi.nlm.nih.gov/projects/gap/
cgi-bin/study.cgi?id=phs000007. The LRP1B gene (SNP
rs3923350, GEE p-value 0.0005) was associated with both
mean BMI and mean WC. We also found association with
the VIP gene (SNP rs620598, GEE p = 0.001), the LEPR
gene (SNP rs2025804, GEE p-value = 0.003), the ADRB1
gene (SNP rs6585258, FBAT p-value 0.004), the NPY2R
gene (SNP rs2880411, p-value = 0.006), the HSD3B1 gene
(rs 4659200, FBAT p-value 0.0007), the ADRA1B gene
(SNP rs952037, GEE p-value = 0.002), IL6R (SNP
rs4129267, FBAT p-value = 0.003), AGTR1 (SNP
rs275678, FBAT p-value = 0.006), and FSHR (SNP
rs1504155; GEE p-value = 0.0004).
Discussion
In our analysis of adiposity-related traits, we found strong
and significant results to SNPs on the Affymetrix 100K
GeneChip. Further, we have confirmed or replicated sev-
eral well-validated genes that have been reported to be
related to adiposity.
One of the top SNPs that we identified via the GEE
method is located in the SSTR2 gene, the somatostatin
Table 1: Phenotype master trait table: exam cycle, and numbers of participants in family plates with phenotype
Exam cycle/s
Phenotype Number 
of traits§
Sample Size Offspring Cohort Adjustment
Body Mass Index; men and women combined 
and separate
46 529–1341 1–7; mean 1–7; change from 1–7 10, 16, 18, 20, 22, 24, 26; mean 
10, 16, 18, 20, 22, 24, 26
*
Weight change 11 468–1115 Change from 1–7 *
Weight; men and women combined and 
separate
43 498–1342 1–7 10, 16, 18, 20, 22, 24, 26 *
Height; men and women combined and 
separate
25 529–1341 1–7 10, 16, 18, 20, 22, 24, 26 *
Waist circumference; men and women 
combined and separate
24 479–1252 4–7; mean 4–7; change from 4–7 20, 22, 23; change from 20–23; **
Subcutaneous fat by computed tomography 2 654 7 - *
Visceral fat by computed tomography 2 653 7 - *
Waist circumference by computed 
tomography
2 664 7 - *
Sagittal diameter by computed tomography 2 665 7 - *
§Refers to number of traits within each group actually analyzed
*All models included age, age-squared, sex, smoking, menopause
**Models additionally adjusted for body mass indexPage 3 of 7
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Table 2: (a) Top association results for mean BMI and mean WC based on GEE p-value; (b) Top 25 association results for mean BMI 
and mean WC based on FBAT p-value; (c) LOD scores of at least 2.0 with accompanying LOD score 1.5 support interval for mean BMI 
and mean WC
Trait SNP Chromosome Physical Position (Mb) GEE p-value FBAT p-value Gene
2a. Top association results for mean BMI and mean WC based on GEE p-value
Mean BMI rs1106683 7 130910780 1.2*10-07 3.2*10-04
Mean WC rs4471028 8 75457530 2.0*10-07 3.2*10-04 GDAP1
Mean WC rs4469448 8 75457665 2.6*10-07 0.003 GDAP1
Mean WC rs6996971 8 75455047 4.9*10-07 0.002 GDAP1
Mean WC rs10504576 8 75429234 7.1*10-07 0.005 GDAP1
Mean WC rs1875517 3 118790257 1.5*10-06 0.002
Mean BMI rs1106684 7 130910920 1.6*10-06 0.002
Mean BMI rs1333026 13 65018785 8.1*10-06 0.209
Mean BMI rs2296465 10 3299647 1.5*10-05 0.262
Mean BMI rs1374489 5 19658900 1.6*10-05 0.348 CDH18
Mean WC rs1466113 17 68676913 2.7*10-05 0.004 SSTR2
Mean BMI rs10486301 7 18183021 2.7*10-05 0.016
Mean BMI rs2221880 5 19420500 3.0*10-05 0.072
Mean WC rs1456873 4 62130929 3.1*10-05 0.005
Mean BMI rs10513097 5 11406101 4.4*10-05 0.022 CTNND2
Mean BMI rs2361128 19 62431059 4.4*10-05 0.004 ZNF264
Mean BMI rs2942329 5 19429660 4.5*10-05 0.089
Mean WC rs4129319 4 88752564 4.7*10-05 0.003 SPARCL1
Mean BMI rs10509361 10 77223192 5.2*10-05 0.044 C10orf11
Mean BMI rs2967001 5 19422000 6.0*10-05 0.074
Mean BMI rs464766 3 162570294 6.1*10-05 0.072 ADMP
Mean BMI rs10487263 7 123603987 7.0*10-05 0.036
Mean BMI rs4922571 11 31643025 7.0*10-05 0.062 ELP4
Mean BMI rs7013836 8 5666540 8.2*10-05 0.103
Mean BMI rs7202384 16 13658225 8.2*10-05 0.002
2b. Top 25 association results for mean BMI and mean WC based on FBAT p-value
Trait SNP Chromosome Physical Location (Mb) GEE p-value FBAT p-value Gene
Mean WC rs10488165 7 132594899 0.011 2.6*10-06 SEC8L1
Mean WC rs2206682 6 56001938 0.011 4.2*10-06 COL21A1
Mean WC rs2223662 6 56001756 0.013 5.1*10-06 COL21A1
Mean WC rs953536 9 111569442 0.007 8.2*10-06 C9orf84
Mean WC rs10517461 4 37789743 2.3*10-04 2.9*10-05 TBC1D1
Mean WC rs7941883 11 123262095 0.084 3.0*10-05 OR8D4|OR4D5|OR6T1
Mean BMI rs10503776 8 25765786 0.009 3.8*10-05 EBF2
Mean BMI rs711702 3 22956280 0.143 4.0*10-05
Mean WC rs4312989 6 55918441 0.075 4.2*10-05
Mean WC rs10519381 5 113700141 0.01 4.4*10-05 KCNN2
Mean WC rs10483872 14 75239061 0.018 4.5*10-05 KIAA0998
Mean WC rs315711 9 111628006 0.008 5.4*10-05 C9orf84
Mean WC rs4715571 6 55917006 0.03 5.9*10-05
Mean WC rs667463 9 111647315 0.004 7.0*10-05 C9orf84
Mean BMI rs7320523 13 67552774 0.193 7.4*10-05
Mean WC rs3752591 22 40664016 0.001 8.5*10-05 C22orf18
Mean WC rs1496389 5 113753570 0.018 9.8*10-05 KCNN2
Mean WC rs1619682 7 133453958 0.14 1.0*10-04 SLC35B4
Mean BMI rs10492197 12 66871874 0.038 1.0*10-04 IFNG|IL26|IL22
Mean WC rs10501467 11 79913437 0.037 1.1*10-04
Mean WC SNP_A-1731932 1 24035982 0.152 1.1*10-04
Mean BMI rs10512326 9 103934100 0.063 1.2*10-04 SMC2L1
Mean BMI rs7533902 1 97791249 0.029 1.2*10-04 DPYD
Mean BMI rs2870950 12 66870973 0.034 1.2*10-04 IFNG|IL26|IL22
Mean WC rs2226351 21 25259810 1.8*10-04 1.3*10-04
2c. LOD scores of at least 2.0 with accompanying LOD score 1.5 support interval for mean BMI and mean WC
Trait SNP Chromosome Physical Position (bp) LOD LOD1.5 Lower Bound (bp) LOD1.5 Upper Bound (bp)
Mean BMI rs9309153 2 48856798 2.3125 44048379 64579948
Mean WC rs1992901 2 121386899 2.2721 116579748 132195205
Mean BMI rs10518418 1 89149134 2.0053 51727132 99668198
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growth hormone secretion. We also identified several
additional SNPs in genes in relation to mean BMI or mean
WC among our list of the top 500 SNPs. The LRP1B gene
is a member of the LDL receptor gene family, and repre-
sents a potentially attractive candidate gene. The VIP gene
(SNP rs620598, GEE p = 0.001) is a member of the gluca-
gon family that plays a role in multiple physiologic and
metabolic pathways, including myocardial contractility,
smooth muscle relaxation, blood pressure lowering and
vasodilation, and glycogenolysis. We also found signifi-
cant associations with multiple genes that have been pre-
viously associated with adiposity-related traits [11].
Using our clustered traits analysis, we identified the
CTNND2 gene, a gene that is part of the catenin family
that may be involved in nutrient absorption in the intes-
tine and signaling with nuclear receptors including PPAR
[19]. We also identified the NR5A2 gene, a gene that is
part of the nuclear receptor subfamily, a family of orphan
receptors. NR5A2 is a key regulator of CYP7A expression
in the liver, and PPM1L (protein phosphatase 1), a gene
that is a suppressor of the SAPK pathway and may be
involved in oxidative stress and apotosis.
Well-replicated candidate genes
We were able to confirm association (i.e. validate) with
the INSIG2 gene (SNP rs7566605, GEE p-value = 0.001).
This same SNP was previously identified in association
with BMI in this same sample using a different analytic
method [18]. We also had nominal significance with a
SNP in LD with the ESR1 Xba1 SNP, and multiple other
SNPs in well-replicated obesity genes, suggesting that the
Affymetrix 100K GeneChip provides a valid tool for
uncovering candidate gene associations with adiposity-
related traits. Of note, some of our SNPs did overlap with
results reported for BMI using different analytic methods
(Herbert et al, http://gmed.bu.edu/about/index.html
[20]).
Comparison with prior linkage results
We have previously identified a locus for BMI on chromo-
some 1 (D1S1665, LOD score 1.85) [7]. This peak falls
within the 1.5 LOD score interval for our current finding
on chromosome 1. We also have previously identified a
LOD score of 2.0 for waist circumference on chromosome
2q14 [9], nearby to our current LOD score of 2.27 for
mean WC. Differences with previously reported results
may stem from our use of different phenotypes.
Strengths and limitations
Strengths of our study lie in our assessment of multiple
measures of BMI and WC in a sample unselected for these
traits, thus improving precision. We also have excellent
assessment of potential confounders that we are able to
adjust for in our residual creation. Because the Framing-
Table 3: Results informed by combination of GEE and FBAT based on p-value of ≤0.01 for GEE or FBAT for 6 out of 8 BMI traits
SNP Chromosome Physical Position (bp) Gene name Mean GEE geometric p-value
rs1106683 7 130910780 3.8*10-6
rs2296465 10 3299647 5.9*10-5
rs10513097 5 11406101 CTNND2 6.8*10-5
rs2361128 19 62431059 ZNF264|AURKC 7.9*10-5
rs1374489 5 19658900 CDH18 1.1*10-4
rs10486301 7 18183021 1.3*10-4
rs1333026 13 65018785 1.3*10-4
rs10509361 10 77223192 C10orf11 1.7*10-4
rs10504368 8 64947097 2.7*10-4
rs947599 10 95256673 C10orf3 3.6*10-4
rs2012187 5 11375037 CTNND2 3.6*10-4
rs6480902 10 80157318 3.9*10-4
rs336583 3 162564683 ADMP 3.9*10-4
rs9290065 3 162259666 PPMIL 4.1*10-4
rs10494810 1 196868239 NR5A2 4.3*10-4
rs2012064 7 18220564 4.5*10-4
rs1869731 8 63972241 FLJ39630 4.7*10-4
rs775748 3 77679150 ROBO2 4.8*10-4
rs10499068 6 113189197 4.9*10-4
rs10236525 7 18184912 5.5*10-4
rs9309770 3 77647000 ROBO2 5.5*10-4
rs1504294 3 68831828 FAM19A4 5.5*10-4
rs7142517 14 54376554 SAMD4|GCH1 5.5*10-4
rs2051545 16 13680100 5.6*10-4
rs910623 1 115336446 TSPAN2 5.8*10-4Page 5 of 7
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to examine trait clustering, which may be more likely to
identify SNPs in coding regions. Limitations exist as well.
Our sample is neither ethnically diverse nor nationally
representative, and it is uncertain how our results would
apply to other ethnic groups. However, in genetics studies,
sample homogeneity is beneficial in order to reduce pop-
ulation stratification. Further, none of these results
reached genome-wide significance; please see the Over-
view [12] for details regarding this threshold. These results
should be considered preliminary, and are likely to con-
tain false negatives and false positives. Therefore, replica-
tion in independent samples is critical. For limitations
pertaining to our genotyping or statistical methods,
including multiple testing, please see the Overview [12].
Conclusion
Adiposity-related traits are associated with SNPs on the
Affymetrix 100K SNP GeneChip. Further work to replicate
some of these SNPs in other samples is necessary. These
data will serve as a resource for replication as more genes
become identified with BMI and WC.
Abbreviations
BMI = body mass index; CVD = cardiovascular disease;
FBAT = Family Based Association Test; GEE = Generalized
Table 4: (a) Comparison of mean BMI and mean WC Results with prior literature for SNPs that are either present in the 100K or in 
LD with a SNP in the 100K; (b) Associations of mean BMI and mean WC with all SNPs in or near genes (up to 200 kb away) for 5 well-
replicated genes in the published literature (INSIG, PPARG, ADIPOQ, ESR1, LEP)* with a p-value < 0.05 in either FBAT or GEE**
4a. Comparison of mean BMI and mean WC Results with prior literature for SNPs that are either present in the 100K or in LD with a SNP in the 100K
Mean BMI p-value Mean WC p-value
Gene Candidate 
SNP
100K SNP Location 
Candidate 
SNP (bp)
Location 
100K SNP 
(bp)
D. prime r2 FBAT GEE FBAT GEE
INSIG2 rs7566605 Rs7566605 118552255 118552255 1 1 0.449 0.001 0.975 0.480
ESR1-Xba1 rs9340799 rs3853250 152255495 152252014 1 0.62 0.047 0.350 0.980 0.105
rs9340799 rs3853251 152255495 152252870 1 0.96 0.309 0.963 0.333 0.336
LEP rs1349419 rs10487506 127471164 127472106 1 0.69 0.422 0.583 0.788 0.848
rs12535747 rs10487505 127472286 127454114 0.83 0.34 0.188 0.286 0.420 0.975
rs12535747 rs10487506 127472286 127472106 1 0.48 0.422 0.583 0.788 0.848
PPARG rs1801282 rs1801282 12368125 12368125 1 1 0.556 0.178 0.290 0.406
4b. Associations of mean BMI and mean WC with all SNPs in or near genes (up to 200 kb away) for 5 well-replicated genes in the published literature 
(INSIG, PPARG, ADIPOQ, ESR1, LEP)* with a p-value < 0.05 in either FBAT or GEE**
Mean BMI p-value Mean WC p-value
Gene SNP Physical 
Position 
(bp)
FBAT GEE FBAT GEE
INSIG rs9284719 118395025 0.148 0.035 0.510 0.925
rs3771942 118425080 0.766 0.005 0.812 0.984
rs10490628 118446520 0.464 0.021 0.765 0.238
rs7566605 118552255 0.449 0.001 0.975 0.480
PPARG rs2938392 12409608 0.158 0.003 0.644 0.244
rs709157 12437024 0.602 0.106 0.091 0.023
rs10510422 12505413 0.806 0.546 0.044 0.720
rs10510423 12526881 0.986 0.753 0.038 0.787
rs2454431 12558068 0.806 0.034 0.268 0.882
rs963163 12632067 0.997 0.047 0.749 0.036
ADIPOQ rs1042464 187878274 0.962 0.231 0.024 0.722
ESR1 rs851982 152117099 0.880 0.538 0.119 0.043
rs10484922 152224431 0.318 0.012 0.067 0.528
rs3853250 152252014 0.047 0.350 0.980 0.105
rs3778099 152510689 0.033 0.367 0.513 0.689
rs9322361 152551257 0.020 0.096 0.122 0.522
*No SNPs in the LEP gene had a p-value < 0.05
**The following number of SNPs were evaluated in the INSIG, PPARG, ADIPOQ, ESR1, and LEP genes: 19, 28, 16, 37, 4Page 6 of 7
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